Delivery Order SPE2DB20D2014-SPE2DB25FD15P
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order valued at $5,383.14 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-Pack 1 mg/0.2 ml auto-injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gvoke HyperPen is an emergency glucagon auto-injector used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $17.5K to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) on July 14, 2025, with completion expected by July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Corporate Office location in Conshohocken, Pennsylvania. The product is an emergency glucagon auto-injector used for treating severe hypoglycemia in patients with diabetes,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $2,832.92. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.51 to AmerisourceBergen Drug Corp for Gvoke HypoPen auto-injectors (1 mg/0.2 mL, 2-pack). This competitive award, issued on July 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD15PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5.7K to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 ml) on September 26, 2025, with completion expected by September 29, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Gvoke HypoPen is an auto-injector device used for emergency treatment of severe hypoglycemia in individuals with diabetes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp demonstrates extensive capability in fulfilling federal medical supply needs across multiple therapeutic domains and customer bases including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/26/25 |